An interventional study of Use of CMAP app for education (in-hospital) and Use of CMAP app (in-home) in Pressure Ulcer, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention
Aim 1 Veteran Focus Group 1 · Aim 1 Clinician Focus Group 1 · Aim 2 Veterans · Aim 3 Veterans · Aim 2 Clinicians · Aim 3 Clinicians · Aim 1 Clinician Focus Group 3 · Aim 1 Veteran Focus Group 3
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 153 studies in Pressure Ulcer with a site in United States — 25 open to participants now, 28 under way, none of them phase 3. Pressure Ulcer · United States.
Among the 153 studies in Pressure Ulcer with a site in United States, this one is the 63rd largest by enrollment of the 118 interventional ones that give a count, is one of 5 that started in 2020, is one of 88 with no phase, and was the 104th registered.
548 studies on the registry are indexed under Pressure Ulcer; 127 are open to participants now.
Browse Pressure Ulcer studies →25 of the 153 studies in Pressure Ulcer with a site in United States are open now. Recruiting first, the newest first:
Integra LifeSciences Corporation · Sites in United States
Ages 21+
University of Miami · Sites in United States
Ages 18–70 · Healthy volunteers
Sequence LifeScience, Inc. · Sites in United States
Ages 18+
North Carolina State University · Sites in United States
Ages 18–75
Biocomposites Ltd · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 61 Pressure Ulcer studies recruiting now, 45 (74%) set no upper age limit and 6 (10%) stop at 75 or younger; 10 take children under 18; 13 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
153 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 11 · Phase 3 3 · Phase 4 12
First in 2000; this study’s year is marked. 5 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 43 is below the median of 70 across 405 interventional studies indexed under Pressure Ulcer.
Median enrollment 48 across the 118 interventional studies, 138 across the 34 observational. Of the 94 that completed or were terminated, 38 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
73 of 153 have an industry lead sponsor. The 10 most frequent:
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
VA Office of Research and Development has 2 studies filed under Pressure Ulcer — fewer than ten, so there is no comparison to draw.
11 of the studies in Pressure Ulcer with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06384183Kerecis Ltd.Kerecis Real-World Fish Skin Graft Registry | 2026-12 |
| NCT05496296ULURU Inc.Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries | 2026-12 |
| NCT07653165West Boca Center for Wound HealingUse of Hydroprep Wound Therapy With Motion Negative Pressure Therapy for Treatment of Chronic Lower Extremity Wounds | 2026-12-31 |
| NCT04726306Northwell HealthDiagnostic Precision and Accuracy Using the Teed Scoring System Versus the O'Neill Grading System | 2026-12-31 |
| NCT05458947Wake Forest University Health SciencesPhysical Therapy Wound Care Modalities in Patients With Spinal Cord Injury (SCI) | 2027-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 153 studies in Pressure Ulcer with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
For Veterans with spinal cord injury who use a wheelchair, pressure injuries related to sitting are a significant daily threat to well-being. Pressure injuries are costly to treat, negatively impact quality of life and community participation, and can be life threatening. Moving or shifting at regular intervals in the wheelchair redistributes harmful pressure and reduces risk for skin breakdown, yet these movements are a challenge to perform consistently. The challenge exists due to lack of sensation to let the individual know they need to shift their weight. Pressure mapping provides a detailed visual representation of pressure distribution and can compensate for impaired sensation. Pressure mapping feedback delivered on-demand on mobile platforms can potentially increase effectiveness in carrying out behaviors to reduce risk for pressure injury when used during clinician-delivered education to set goals and monitor progress and when used at home as a self-management strategy.
Objectives: The long-term goal of this project is to improve the effectiveness of pressure injury prevention education by clinicians and self-management by Veterans with spinal cord injury (SCI) through a methodical development and testing of a mobile platform based pressure mapping system called "Comprehensive Mobile Assessment of Pressure" (CMAP). The targeted risk-reduction behavior in this project is the effective use of weight shifts when sitting in a wheelchair by improving consistency, frequency, duration, and quality of movements to redistribute pressure. CMAP provides visual cues as well as individually customizable reminders that are designed to compensate for the lack of sensation that prevents the use of natural cues to redistribute pressure, by wheelchair users. An updated CMAP system will serve two important objectives: 1) assist clinicians in assessment, individualized goal-setting, and monitoring the Veteran with SCI's progress toward pressure injury prevention behavior goals while in the hospital setting; and 2) assist clinicians with individualized setup and education of the Veteran with SCI for using the CMAP system in the home setting as a self-management strategy for pressure injury prevention.
Specific Aims: The specific aims of this study include: 1a) hardware expansion to improve functionality of the CMAP system to add a docking and charging station and use of CMAP on a smartwatch based on Veteran preferences and 1b) software expansion to enhance clinical education for pressure injury prevention education, with requirements provided by clinicians; 2) determine usability of the refined CMAP system when it is integrated into patient education for Veteran's with acute SCI during their inpatient rehabilitation stay, and 3) a determine usability and efficacy of the refined CMAP system for clinician-delivered pressure injury prevention education, followed by Veteran use of CMAP in their daily routines at home.
Study Design: This four-year study will have multiple stages and will use a mixed methods approach that includes iterative focus groups and interviews with Veterans who have SCI and with clinicians who provide pressure injury prevention education to Veterans with SCI; self-efficacy and usability surveys for both Veterans and clinicians; pilot testing of CMAP during inpatient rehabilitation and testing during outpatient visits. Repeated measures will be used to evaluate changes within subject for completion of weight shifts while using CMAP, compared to periods when not using CMAP.
Methods: During the first two years, improvements to CMAP hardware and software will be guided by experience-based design guided requirements learned about through iterative focus groups including Veterans with SCI/D (n=10) and clinicians (n=10). Usability will be measured at each iteration of development using the System Usability Scale (SUS) and the User Experience Questionnaire (UEQ). The focus groups will be repeated to ensure alignment between development progress and the requirements identified by the focus groups. During the inpatient pilot test, clinician (n=3) and Veteran (n=6) self-efficacy will be measured. Veterans will complete selected sub-scales from the Skin Care Belief Scale and clinicians will answer survey questions developed specifically around providing education for performing weight shifts effectively. Veteran progress toward weight shift goals will be measured through performance monitoring within the CMAP app; Actual performance will be assessed against the individualized goals set by the clinician. During the outpatient testing, Veterans (n=20) will use CMAP at home for 2 weeks after receiving education and individualized goals for weight shift performance by clinicians. While at home, trunk movements will be monitored via actigraphy to monitor weight shift frequency to compare to baseline trunk movement data, weight shift performance data within CMAP app, and finally, compared with individualized goals for performing weight shifts. Self efficacy and usability (SUS and UEQ) of the overall system in both settings will be measured.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For Aim 1a:
For Aim 2: Veteran adults aged 18-80, male and female, with a recent spinal cord injury (C4 and below) or a spinal cord disorder with impaired sensory function, who are currently in inpatient rehabilitation with at least 1 week prior to discharge. Participants must demonstrate ability to access the CMAP system application on a mobile phone or tablet independently.
For Aim 3:
Clinicians inclusion Criteria for Aim 1b; Aims 2 and 3:
Exclusion Criteria:
For Aim 1a:
For Aims 2, and 3:
Veterans will inform study staff regarding desired device design refinements over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.
Clinicians will inform study staff regarding desired app design changes over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.
Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.
Device: Use of CMAP app for education (in-hospital)
The Veteran will use the CMAP system at home for two weeks to use in their daily routines, along with wearing the acti-graph one week prior, two weeks during and one week after CMAP usage.
Device: Use of CMAP app (in-home)
Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.
Device: Use of CMAP app for education (in-hospital)
The Veteran will use the CMAP system at home for two weeks to use in their daily routines, along with wearing the acti-graph one week prior, two weeks during and one week after CMAP usage.
Device: Use of CMAP app (in-home)
Clinicians will inform study staff regarding desired app design changes over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.
Veterans will inform study staff regarding desired device design refinements over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.
Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.
The Veteran will use the CMAP system at home for two weeks during their daily routines.
Change in Usability as Measured by System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the Smart watch as part of the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Usability as Measured by User Experience Questionnaire (UEQ)
The User Experience Questionnaire (UEQ) is a 26 item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participant's (Veterans) impression of the of their experience with the Smart watch as part of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Change in Usability as Measured by System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the newly developed educational formats in the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Change in Usability as Measured by User Experience Questionnaire (UEQ)
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the newly developed educational formats of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Change in Usability as Measured by System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it during their acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model
Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
Change in Usability as Measured by User Experience Questionnaire (UEQ)
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system after using it during Veterans' during their acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
Change in Usability as Measured by System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model
Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
Change in Usability as Measured by User Experience Questionnaire (UEQ)
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats after using it for Veterans' acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
Change in Usability as Measured by System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
Change in Usability as Measured by User Experience Questionnaire (UEQ)
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
Change in Usability as Measured by System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
Change in Usability as Measured by User Experience Questionnaire (UEQ)
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
Pressure Ulcer Knowledge Test
The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.
Time frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment)
Therapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries
This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.
Time frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment for each Veteran case)
Pressure Ulcer Knowledge Test
The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.
Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
Therapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries
This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.
Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
| Milestone | Aim 1 Veteran Focus Group 1 | Aim 1 Clinician Focus Group 1 | Aim 1 Veteran Focus Group 3 | Aim 1 Clinician Focus Group 3 | Aim 2 Veterans (In-Hospital CMAP App) | Aim 2 Clinicians (In-Hospital CMAP App) | Aim 3 Veterans (In-Home CMAP App) | Aim 3 Clinicians (In-Home CMAP App) |
|---|---|---|---|---|---|---|---|---|
| Started | 7 | 6 | 7 | 5 | 5 | 5 | 6 | 2 |
| Completed | 7 | 6 | 7 | 5 | 5 | 5 | 6 | 2 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the Smart watch as part of the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 1 Veteran Focus Group 1 | Aim 1 Veteran Focus Group 3 |
|---|---|---|
| Change in Usability as Measured by System Usability Scale (SUS) | 80.4167 ± 15.6058 | 82.50 ± 8.6603 |
The User Experience Questionnaire (UEQ) is a 26 item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participant's (Veterans) impression of the of their experience with the Smart watch as part of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 1 Veteran Focus Group 1 | Aim 1 Veteran Focus Group 3 |
|---|---|---|
| UEQ Attractiveness | 2.4183 ± 0.9536 | 1.78 ± 0.9753 |
| UEQ Perspicuity | 2.5833 ± 0.4378 | 1.75 ± 1.00 |
| UEQ Efficiency | 1.875 ± 1.0338 | 1.9167 ± 0.8036 |
| UEQ Dependability | 2.4583 ± 0.5342 | 1.8333 ± 1.0104 |
| UEQ Stimulation | 2.2083 ± 1.177 | 2.25 ± 0.75 |
| UEQ Novelty | 2.0833 ± 1.3102 | 1.8333 ± 1.2583 |
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the newly developed educational formats in the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 1 Clinician Focus Group 1 | Aim 1 Clinician Focus Group 3 |
|---|---|---|
| Change in Usability as Measured by System Usability Scale (SUS) | 71.67 ± 6.83 | 79.00 ± 7.2 |
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the newly developed educational formats of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 1 Clinician Focus Group 1 | Aim 1 Clinician Focus Group 3 |
|---|---|---|
| UEQ Attractiveness | 1.75 ± 0.46 | 2.4 ± 0.38 |
| UEQ Perspicuity | 1.21 ± 1.8 | 1.8 ± 0.54 |
| UEQ Efficiency | 1.63 ± 0.38 | 2.3 ± 0.48 |
| UEQ Dependability | 1.54 ± 0.49 | 2.15 ± 0.55 |
| UEQ Stimulation | 2.25 ± 0.27 | 2.7 ± 0.33 |
| UEQ Novelty | 2.00 ± 0.76 | 2.85 ± 0.14 |
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it during their acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model
| score on a scale | Aim 1 Veteran Focus Group 3 | Aim 2 Veterans |
|---|---|---|
| Change in Usability as Measured by System Usability Scale (SUS) | 82.5 ± 8.6603 | 83.00 ± 13.0384 |
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system after using it during Veterans' during their acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 1 Veteran Focus Group 3 | Aim 2 Veterans |
|---|---|---|
| UEQ Attractiveness | 1.78 ± 0.9753 | 1.7333 ± 0.5963 |
| UEQ Perspicuity | 1.75 ± 1.0 | 2.05 ± 0.9253 |
| UEQ Efficiency | 1.9167 ± 0.8036 | 1.8 ± 0.8551 |
| UEQ Dependability | 1.8333 ± 1.0104 | 1.35 ± 1.3062 |
| UEQ Stimulation | 2.25 ± 1.4 | 1.4 ± 1.245 |
| UEQ Novelty | 1.8333 ± 0.95 | 0.95 ± 1.4076 |
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model
| score on a scale | Aim 1 Clinician Focus Group 3 | Aim 2 Clinicians |
|---|---|---|
| Change in Usability as Measured by System Usability Scale (SUS) | 82.5 ± 8.6603 | 69.5 ± 5.1235 |
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats after using it for Veterans' acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 1 Clinician Focus Group 3 | Aim 2 Clinicians |
|---|---|---|
| UEQ Attractiveness | 1.78 ± 0.9753 | 1.3667 ± 0.7397 |
| UEQ Perspicuity | 1.75 ± 1.00 | 1.2 ± 0.542 |
| UEQ Efficiency | 1.9167 ± 0.8036 | 1.35 ± 0.6982 |
| UEQ Dependability | 1.8333 ± 1.0104 | 1.25 ± 0.75 |
| UEQ Stimulation | 2.25 ± 0.75 | 2.00 ± 0.8478 |
| UEQ Novelty | 1.8333 ± 1.2583 | 2.05 ± 0.7159 |
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 3 Veterans (In-Home CMAP App) |
|---|---|
| Aim 3 Baseline | 76.25 ± 14.7267 |
| End of Aim 3 Participation | 85.8333 ± 9.1742 |
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 3 Veterans (In-Home CMAP App) |
|---|---|
| Baseline UEQ Attractiveness | 1.4667 ± 0.2173 |
| End of Aim 3 UEQ Attractiveness | 2.2778 ± 0.4172 |
| Baseline UEQ Perspicuity | 2.3 ± 0.7374 |
| End of Aim 3 UEQ Perspicuity | 2.8333 ± 0.1291 |
| Baseline UEQ Efficiency | 2.1167 ± 0.1624 |
| End of Aim 3 UEQ Efficiency | 2.25 ± 0.5 |
| Baseline UEQ Dependability | 1.65 ± 0.3791 |
| End of Aim 3 UEQ Dependability | 2.1667 ± 0.5845 |
| Baseline UEQ Stimulation | 1.65 ± 0.3791 |
| End of Aim 3 UEQ Stimulation | 2.5417 ± 0.4852 |
| Baseline UEQ Novelty | 2.0 ± 0.5863 |
| End of Aim 3 UEQ Novelty | 2.4167 ± 0.5627 |
The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 3 Clinicians (In-Home CMAP App) |
|---|---|
| Aim 3 Baseline | 66.25 ± 47.5 |
| End of Aim 3 Activities | 47.5 ± 17.6777 |
The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.
| score on a scale | Aim 3 Clinicians (In-Home CMAP App) |
|---|---|
| Baseline UEQ Attractiveness | 1.1667 ± 0 |
| End of Aim 3 UEQ Attractiveness | 0.7500 ± 0.5893 |
| Baseline UEQ Perspicuity | 0.875 ± 0.1768 |
| End of Aim 3 UEQ Perspicuity | 0.625 ± 0.8839 |
| Baseline UEQ Efficiency | 0.875 ± 0.1768 |
| End of Aim 3 UEQ Efficiency | 0.625 ± 0.5303 |
| Baseline UEQ Dependability | 0.375 ± 0.8839 |
| End of Aim 3 UEQ Dependability | 0 ± 0.7071 |
| Baseline UEQ Stimulation | 1.75 ± 1.0607 |
| End of Aim 3 UEQ Stimulation | 2.25 ± 0 |
| Baseline UEQ Novelty | 1.75 ± 0.3536 |
| End of Aim 3 UEQ Novelty | 2.0 ± 0 |
The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.
| score on a scale | Aim 2 Veterans (In-Hospital CMAP App) |
|---|---|
| Aim 2 Baseline | 14.8 ± 1.9235 |
| End of Aim 2 Intervention | 15.0 ± 2.0 |
This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.
| score on a scale | Aim 2 Clinicians (In-Hospital CMAP App) |
|---|---|
| Aim 2 Baseline | 29.6 ± 8.9051 |
| End of Aim 2 Intervention | 35.6 ± 5.3198 |
The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.
| score on a scale | Aim 3 Veterans (In-Home CMAP App) |
|---|---|
| Aim 3 Baseline | 16.3333 ± 0.8165 |
| End of Aim 3 Participation | 15.5833 ± 1.0206 |
This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.
| score on a scale | Aim 3 Clinicians (In-Home CMAP App) |
|---|---|
| Aim 3 Baseline | 30.5 ± 2.8284 |
| End of Aim 3 Activities | 32.0 ± 4.9497 |
Collected over From enrollment to study completion, up to 4 years. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Aim 1 Veteran Focus Group 1 | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
| Aim 1 Clinician Focus Group 1 | 0/6 (0%) | 0/6 (0%) | 0/6 (0%) |
| Aim 1 Veteran Focus Group 3 | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
| Aim 1 Clinician Focus Group 3 | 0/5 (0%) | 0/5 (0%) | 0/5 (0%) |
| Aim 2 Veterans (In-Hospital CMAP App) | 0/5 (0%) | 0/5 (0%) | 0/5 (0%) |
| Aim 2 Clinicians (In-Hospital CMAP App) | 0/5 (0%) | 0/5 (0%) | 0/5 (0%) |
| Aim 3 Veterans (In-Home CMAP App) | 0/6 (0%) | 0/6 (0%) | 0/6 (0%) |
| Aim 3 Clinicians (In-Home CMAP App) | 0/2 (0%) | 0/2 (0%) | 0/2 (0%) |
| Age, Continuous(years) | Aim 1 Veteran Focus Group 1 | Aim 1 Clinician Focus Group 1 | Aim 1 Veteran Focus Group 3 | Aim 1 Clinician Focus Group 3 | Aim 2 Veterans (In-Hospital CMAP App) | Aim 2 Clinicians (In-Hospital CMAP App) | Aim 3 Veterans (In-Home CMAP App) | Aim 3 Clinicians (In-Home CMAP App) | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mean | 54.3 ± 11.467 | 35 ± 8.37 | 54.3 ± 11.467 | 33.7 ± 7.23 | 52.33 ± 19.91 | 33.7 ± 2.51 | 53.57 ± 17.75 | 32.5 ± 2.12 | 43.57 ± 10.82 |
| Sex: Female, Male(Participants) | Aim 1 Veteran Focus Group 1 | Aim 1 Clinician Focus Group 1 | Aim 1 Veteran Focus Group 3 | Aim 1 Clinician Focus Group 3 | Aim 2 Veterans (In-Hospital CMAP App) | Aim 2 Clinicians (In-Hospital CMAP App) | Aim 3 Veterans (In-Home CMAP App) | Aim 3 Clinicians (In-Home CMAP App) | Total |
|---|---|---|---|---|---|---|---|---|---|
| Female | 1 | 4 | 1 | 4 | 0 | 3 | 0 | 1 | 14 |
| Male | 6 | 2 | 6 | 1 | 5 | 2 | 6 | 1 | 29 |
| Race (NIH/OMB)(Participants) | Aim 1 Veteran Focus Group 1 | Aim 1 Clinician Focus Group 1 | Aim 1 Veteran Focus Group 3 | Aim 1 Clinician Focus Group 3 | Aim 2 Veterans (In-Hospital CMAP App) | Aim 2 Clinicians (In-Hospital CMAP App) | Aim 3 Veterans (In-Home CMAP App) | Aim 3 Clinicians (In-Home CMAP App) | Total |
|---|---|---|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| White | 7 | 6 | 7 | 5 | 5 | 5 | 6 | 2 | 43 |
| More than one race | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ethnicity (NIH/OMB)(Participants) | Aim 1 Veteran Focus Group 1 | Aim 1 Clinician Focus Group 1 | Aim 1 Veteran Focus Group 3 | Aim 1 Clinician Focus Group 3 | Aim 2 Veterans (In-Hospital CMAP App) | Aim 2 Clinicians (In-Hospital CMAP App) | Aim 3 Veterans (In-Home CMAP App) | Aim 3 Clinicians (In-Home CMAP App) | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not Hispanic or Latino | 7 | 6 | 7 | 5 | 5 | 5 | 6 | 2 | 43 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified data will be shared upon request, per VA requirements.
Supporting information: Study protocol, Informed consent form
Time frame: At the completion of the study.
Access criteria: Upon request once the study data analysis are completed and published.
Ran from Jun 2020 to primary completion in Jul 2025, 61 months.
Results were first posted in Oct 2026, 1 year 2 months after primary completion.
Of 181 non-industry interventional studies with no phase under Pressure Ulcer, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 61 months is above that.
Counting every sponsor, half of 210 studies reached it within 11 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Aim 1 Veteran Focus Group 1 · Aim 1 Clinician Focus Group 1 · Aim 2 Veterans · Aim 3 Veterans · Aim 2 Clinicians · Aim 3 Clinicians · Aim 1 Clinician Focus Group 3 · Aim 1 Veteran Focus Group 3
Aim 1 Veteran Focus Group 1 · Aim 1 Clinician Focus Group 1 · Aim 2 Veterans · Aim 3 Veterans · Aim 2 Clinicians · Aim 3 Clinicians · Aim 1 Clinician Focus Group 3 · Aim 1 Veteran Focus Group 3
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →